US Bancorp’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-11,284
Closed -$5K 3748
2019
Q1
$5K Buy
11,284
+9,229
+449% +$9.69K ﹤0.01% 3265
2018
Q4
$3K Hold
2,055
﹤0.01% 3379
2018
Q3
$8K Sell
2,055
-1,260
-38% -$7.62K ﹤0.01% 3223
2018
Q2
$29K Sell
3,315
-1,494
-31% -$18.2K ﹤0.01% 2814
2018
Q1
$62K Sell
4,809
-1,310
-21% -$14.9K ﹤0.01% 2488
2017
Q4
$66K Buy
6,119
+3,516
+135% +$44.1K ﹤0.01% 2460
2017
Q3
$42K Buy
2,603
+548
+27% +$10.4K ﹤0.01% 2644
2017
Q2
$45K Buy
+2,055
New +$46.9K ﹤0.01% 2599

Other funds holding AKAO

US Bancorp's AKAO Position: Q2 2019 in Review

US Bancorp sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 11,284 shares — an estimated $5K sold.

US Bancorp first reported a position in AKAO in Q2 2017 and held it in 8 quarters. The position peaked at $66K in Q4 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • US Bancorp reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • US Bancorp sold 11,284 Achaogen Inc shares in Q2 2019, an estimated $5K.
  • US Bancorp first reported a position in Achaogen Inc in Q2 2017 and held it in 8 quarters.
  • US Bancorp's Achaogen Inc position peaked at $66K in Q4 2017.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on US Bancorp's 13F filing for Q2 2019, filed 13 Aug 2019.